Changes in brain metabolites in frequently relapsing bipolar patients treated with long-acting risperidone

被引：0

作者：

Yurgelun-Todd, Deborah A. ^{[1
]}

Olson, David P. ^{[1
]}

Jensen, J. E. ^{[1
]}

Ross, Amy ^{[1
]}

Gruber, Staci A. ^{[1
]}

Silveri, Marisa M. ^{[1
]}

Renshaw, Perry F. ^{[1
]}

Eliassen, James C. ^{[1
]}

Chu, Wen-Jang ^{[1
]}

Lee, Jing-Huei ^{[1
]}

Adler, Caleb M. ^{[1
]}

Kujawa, Mary ^{[1
]}

Gharabawi, Georges ^{[1
]}

Strakowski, Stephen M. ^{[1
]}

机构：

[1] McLean Hosp, Harvard Med Sch, Belmont, MA 02178 USA

来源：

NEUROPSYCHOPHARMACOLOGY | 2006年 / 31卷

关键词：

D O I：

暂无

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

引用

页码：S86 / S86

页数：1

共 50 条

[41] Long-acting risperidone: a review of its role in the treatment of bipolar disorder
David E. Kemp
Fatih Canan
Benjamin I. Goldstein
Roger S. McIntyre
Advances in Therapy, 2009, 26 : 588 - 599
[42] Association of improvement in quality of life and psychiatric symptomatology in patients treated with long-acting risperidone
Rabonowitz, J
Fleischhacker, WW
Lasser, R
Mehnert, A
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S238 - S238
[43] Risperidone long-acting injectable in dual diagnosed patients
Batlle, E
Andres, I
Bastardas, J
Fernandez, T
Ferrer, J
Lozano, L
Martinez, J
Menus, R
Mola, M
Vazquez, G
Vazquez, JM
EUROPEAN PSYCHIATRY, 2005, 20 : S30 - S31
[44] Long-acting risperidone in stable patients with schizoaffective disorder
Mohl, A
Westlye, K
Opjordsmoen, S
Lex, A
Schreiner, A
Benoit, M
Bräunig, P
Medori, R
JOURNAL OF PSYCHOPHARMACOLOGY, 2005, 19 (05) : 22 - 31
[45] Risperidone long-acting injection helping treatment adherence and symptom control of Pediatric bipolar patients
Fu-I, L.
Stravogiannis, A.
Wang, Y. P.
Boarati, M. A.
BIPOLAR DISORDERS, 2008, 10 : 43 - 43
[46] Efficacy and tolerability of long-acting risperidone in patients previously treated with opal atypical antipsychotics
Schreiner, A
Moeller, HJ
SCHIZOPHRENIA RESEARCH, 2006, 81 : 96 - 97
[47] French psychotic patients treated with risperidone long-acting injectable: Improved efficacy and safety
Llorca, P-M.
Dumont, P.
Palazzolo, J.
Raymondet, P.
Moreau-Mallet, V.
Bouhours, P.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S270 - S270
[48] New levels of outcome for first-episode patients treated with long-acting risperidone
Emsley, R. A.
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S571 - S571
[49] Gallstones frequently develop in patients treated with monthly IM injections of long-acting octreotide
Reactions Weekly, 2001, 847 (1) : 3 - 3
[50] COST-EFFECTIVENESS OF LONG-ACTING OLANZAPINE VERSUS LONG-ACTING RISPERIDONE IN PATIENTS WITH SCHIZOPHRENIA IN SPAIN
Dilla, T.
O'Donohoe, P.
Moeller, J.
Alvarez, M.
Sacristan, J.
San, L.
Happich, M.
Tockhorn, A.
VALUE IN HEALTH, 2011, 14 (07) : A292 - A292

← 1 2 3 4 5 →